ivabradine has been researched along with Abnormality, Heart in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Joshi, S; Kumar, G; Kumar, V; Ramamurthy, R; Sharma, V; Tiwari, N | 1 |
Chokhandre, M; Dharod, D; Joshi, S; Khan, N; Mandrekar, A; Salvi, P | 1 |
Ames, WA; Machovec, KA | 1 |
Imamura, T | 1 |
Jæger, KH; Tveito, A; Wall, S | 1 |
1 review(s) available for ivabradine and Abnormality, Heart
Article | Year |
---|---|
Use of Ivabradine in the Treatment of Tachyarrhythmias After Surgery for Congenital Heart Diseases.
Topics: Benzazepines; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Ivabradine; Tachycardia | 2020 |
4 other study(ies) available for ivabradine and Abnormality, Heart
Article | Year |
---|---|
Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study.
Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Electrocardiography; Female; Heart Defects, Congenital; Heart Rate; Humans; Infant; Ivabradine; Male; Postoperative Complications; Retrospective Studies; Tachycardia, Ectopic Junctional; Treatment Outcome | 2019 |
Big Syringe, Little Syringe.
Topics: Heart Defects, Congenital; Humans; Ivabradine; Syringes; Tachycardia | 2020 |
What Is the Optimal Heart Rate Control for Atrial Tachyarrhythmia Following Cardiac Surgery?
Topics: Cardiac Surgical Procedures; Heart Defects, Congenital; Heart Rate; Humans; Ivabradine; Tachycardia | 2021 |
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adult; Ajmaline; Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Computational Biology; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Heart Conduction System; Heart Defects, Congenital; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ivabradine; Mexiletine; Models, Cardiovascular; Mutation; Myocytes, Cardiac; Quinidine; Translational Research, Biomedical | 2021 |